Medication Reconciliation

Historical Context & Motivation

The concept of medication reconciliation arose from a growing recognition that medication errors at transitions of care—admission, transfer, and discharge—constitute one of the most significant and preventable threats to patient safety. Studies in the late 1990s and early 2000s revealed that up to 67% of hospitalized patients had at least one unintended medication discrepancy at admission, many of which carried the potential to cause serious harm. These findings catalyzed a formal, systematic process designed to create a single, verified list of every medication a patient is taking and to compare that list against provider orders at each transition point. Medication reconciliation has since evolved from a loosely defined best practice into a national patient safety priority with regulatory mandates, standardized processes, and interprofessional accountability frameworks.

Despite decades of awareness, unintended medication discrepancies remain alarmingly common. Research consistently shows that 30–70% of patients experience at least one discrepancy at hospital admission, and approximately one-third of these discrepancies have the potential to cause moderate to severe harm. The central question driving medication reconciliation is straightforward yet profoundly important: How do we ensure that every patient's medication regimen is accurate, intentional, and safely communicated across every point of care transition?

Core Principles & Definitions

Medication reconciliation is fundamentally a three-step comparative process. The clinician first compiles the Best Possible Medication History (BPMH)—a comprehensive, verified list of all medications the patient is actually taking, including prescription drugs, over-the-counter products, herbals, supplements, and recreational substances. Next, this list is compared against the current set of medication orders (at admission, transfer, or discharge). Finally, any discrepancies are identified, classified as intentional or unintentional, and resolved through collaboration with the prescriber and the patient. This process must occur at every transition of care—a term encompassing admission, intra-facility transfer, and discharge to home, long-term care, or another facility.

The Medication Reconciliation Process — Visual Overview

As the diagram illustrates, the medication reconciliation process follows a linear yet iterative pathway. The pharmacist or other qualified clinician begins by collecting a Best Possible Medication History using multiple, corroborating sources—a patient interview alone is insufficient because patients frequently omit OTC products, misstate doses, or confuse generic and brand names. Pharmacy dispensing records, medication administration records from referring facilities, physical inspection of pill bottles, and caregiver input each provide complementary information. Once the BPMH is assembled, each medication is clarified for accuracy—correct drug name, strength, formulation, route, and frequency. This clarified list is then compared against the provider's active orders, and every discrepancy is flagged. A discrepancy is unintentional unless the prescriber explicitly documents the change as a deliberate clinical decision. The final step—documentation and communication—closes the loop by transmitting the reconciled list forward to the patient and the next care team.

How Medication Reconciliation Works in Practice

Discrepancy Classification Framework

When the BPMH is compared against active medication orders, clinicians encounter five principal categories of discrepancies. Understanding this taxonomy is critical because each type carries a distinct risk profile and requires a different resolution pathway. An omission occurs when a home medication is absent from the admission orders without documented justification—this is the single most common discrepancy type, accounting for approximately 40–50% of all unintended discrepancies. A commission (or addition) is the ordering of a medication the patient was not previously taking, without a clear clinical indication documented in the chart. A dose, frequency, or route discrepancy occurs when the ordered parameters differ from the home regimen without explanation. A therapeutic duplication arises when two agents from the same pharmacologic class are prescribed concurrently without clear rationale. Finally, a therapeutic substitution may be intentional (formulary-driven) or unintentional, and must be verified with the prescriber.

The Pharmacist's Role in the Reconciliation Process

Pharmacists are uniquely positioned to lead medication reconciliation because of their comprehensive drug knowledge, access to dispensing records, and training in patient communication regarding medication use. The pharmacist conducts a structured interview that probes beyond prescription medications to include OTC agents, herbal products, vitamins, eye drops, inhalers, topical preparations, and any medications recently discontinued. The interview should also assess adherence—a patient who reports 'sometimes forgetting' their amlodipine may not be a true candidate for continuation of the same dose. Clinical judgment is required at every step: the pharmacist must determine whether a discrepancy is clinically significant, communicate recommendations clearly to prescribers, and ensure the patient understands any changes at discharge. Evidence from randomized controlled trials demonstrates that pharmacist-led reconciliation reduces the rate of unintended discrepancies by 50–80% compared with physician-only or nursing-only processes.

Detailed Breakdown — Types, Severity, and Risk Factors

Not all medication discrepancies carry equal clinical significance. A systematic approach to severity classification helps pharmacists prioritize interventions, allocate limited time effectively, and communicate risk to prescribers with appropriate urgency. The following visual framework stratifies discrepancies by their potential for patient harm, guiding the urgency and type of intervention required.

High-Alert Medications Requiring Priority Reconciliation

The Institute for Safe Medication Practices (ISMP) maintains a list of high-alert medications that bear a heightened risk of causing significant patient harm when used in error. During medication reconciliation, these agents should receive the highest priority. The mnemonic A PINCH is commonly used to remember the high-risk categories: Anti-infectives, Potassium and other electrolytes, Insulin, Narcotics (opioids), Chemotherapeutic agents, and Heparin and anticoagulants. Discrepancies involving these drug classes should be flagged for immediate prescriber notification and resolution.

• Polypharmacy (≥5 chronic medications) is the single strongest predictor of reconciliation discrepancies; every additional medication increases discrepancy risk by approximately 5–10%.
• Emergency admissions carry higher discrepancy rates than elective admissions because the BPMH is often collected under time pressure and the patient may be unable to provide a reliable history.
• Elderly patients (≥65 years) frequently manage multiple chronic conditions, use multiple pharmacies, and may have cognitive barriers to providing accurate medication histories.
• Transitions involving different EHR systems create information gaps when medication lists from separate platforms cannot be electronically cross-referenced.

Worked Example — Admission Reconciliation Case

The following case demonstrates how a pharmacist performs medication reconciliation at hospital admission. Pay close attention to the systematic comparison of the BPMH against admission orders and the clinical reasoning behind each discrepancy resolution.

Strengths, Barriers, and Interprofessional Considerations

Medication reconciliation has demonstrated robust clinical value across diverse healthcare settings, but implementation remains challenging. Understanding both the strengths and barriers of reconciliation programs is essential for pharmacy professionals who will design, execute, and advocate for these systems.

Connection to Advanced Practice & Emerging Models

While the foundational medication reconciliation process is well established, advanced practice models and emerging technologies are expanding its scope and effectiveness. Understanding where basic reconciliation ends and advanced, person-centered models begin helps pharmacy students appreciate the trajectory of the profession and the opportunities for impactful clinical practice.

Looking forward, the field is moving toward continuous reconciliation rather than episodic, transition-based reconciliation. Health information exchanges (HIEs) and prescription drug monitoring programs (PDMPs) are beginning to provide real-time, cross-platform medication data that can alert clinicians to discrepancies before they become errors. Artificial intelligence algorithms are being developed to flag high-risk discrepancies automatically upon order entry, reducing the cognitive burden on pharmacists while maintaining safety. Telepharmacy models extend reconciliation services to rural and underserved populations that lack on-site clinical pharmacists. As value-based care models increasingly tie reimbursement to 30-day readmission rates and medication safety metrics, pharmacist-led reconciliation becomes not only a clinical imperative but also a financial one for health systems.

Practice Problems

Medication Reconciliation — Key Concepts Review